PYYIF yields 2.39% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, PYYIF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PYYIF + PFE for your $10,000?
Promotora y Operadora de Infraestructura, S. A. B. de C. V. engages in the construction, operation, maintenance, financing, and promotion of infrastructure projects in Mexico. Its projects include heavy construction projects, such as toll roads, ports, tunnels, dams, bridges, airports, and railways; industrial construction projects comprising petrochemical, industrial, wastewater treatment, and power generating plants; and urban construction projects, such as parking lots, museums, parks, education centers, buildings, water systems, public transportation systems, landfills, and hospitals. The company produces various asphalt concretes; basalt aggregates, including gravel, sand, seal, ballast, hydraulic base, sub-base, and tepetate; and central guard rails for roads, and various other precast concrete materials, as well as exploits stone aggregates. In addition, the company provides services, such as reception, storage, and shipment of goods; hauling or transfer of goods; loading and unloading ships; container filling and emptying; general cargo storage; and mooring and unmooring of ropes, as well as foreign trade merchandise handling, storage, and custody services. Promotora y Operadora de Infraestructura, S. A. B. de C. V. was founded in 1969 and is based in Mexico City, Mexico.
Full PYYIF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.